Concepedia

Steve Hoagland

SH

3

Publications

176

Citations

3

H-Index

2018

Active since

Affiliations

Pfizer (United States)(Current)

Steve Hoagland is an author at Pfizer (United States) specializing in medicinal chemistry, biomolecular engineering, and engineering.

Top concepts

Medicinal ChemistryBiomolecular EngineeringEngineeringBiochemistryDrug DiscoveryNatural SciencesMedicineBiocatalysisBiosynthesisPharmacology

Publications per year

2018–2021

3

Publications

3

Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor

Rajesh Kumar, Michael J. Karmilowicz, Dylan Burke et al. · Nature Catalysis · 2021 · 129 citations

Medicinal Chemistry, Engineering, Commercial Manufacturing +10

Continuous Production of Anhydrous <i>tert</i>-Butyl Hydroperoxide in Nonane Using Membrane Pervaporation and Its Application in Flow Oxidation of a γ-Butyrolactam

Bryan Li, Steven M. Guinness, Steve Hoagland et al. · Organic Process Research & Development · 2018 · 33 citations

Advanced Oxidation Process, Medicinal Chemistry, Chemical Engineering +15

Overcoming the Challenges of Making a Single Enantiomer N-1 Substituted Tetrazole Prodrug Using a Tin-Mediated Alkylation and Enzymatic Resolution

Anne Akin, Mark T. Barilla, Thomas A. Brandt et al. · Organic Process Research & Development · 2019 · 14 citations

Chemical Biology, Pharmaceutical Chemistry, Medicinal Chemistry +18

Rows per page

1–3 of 3